QSAM Biosciences Income
What is the Income of QSAM Biosciences?
The Income of QSAM Biosciences, Inc. is -$8.73
What is the definition of Income?
Net income available for common shareholders equals net income minus preferred dividends paid.
ttm (trailing twelve months)
Net income available to common shareholders are the profits remaining after the company pays all of its suppliers, employees, service providers, creditors, and preferred shareholders. In other words, this is revenue less all expenses and preferred dividends. The number measures common shareholders' claim on the company's cash flows.
Income of companies in the Health Care sector on OTC compared to QSAM Biosciences
What does QSAM Biosciences do?
QSAM Biosciences, Inc., a clinical stage biotechnology company, develops drugs for the treatment of bone cancer. The company is involved in the development of CycloSam (Samaium-153 DOTMP), a clinical-stage novel radiopharmaceutical for the treatment of bone cancer and related diseases. It has a license agreement with IGL Pharma, Inc. The company was formerly known as Q2Earth, Inc. and changed its name to QSAM Biosciences, Inc. in September 2020. QSAM Biosciences, Inc. was founded in 2004 and is based in Austin, Texas.
Companies with income similar to QSAM Biosciences
- Osisko Mining has Income of -CAD$8.75
- BRT Apartments Corp has Income of -$8.75
- Highbank Resources has Income of -CAD$8.74
- Novoheart has Income of -CAD$8.74
- BCC Fuba India has Income of -₨8.74
- Technologies has Income of -AUD$8.73
- QSAM Biosciences has Income of -$8.73
- Sharing Economy International I has Income of -$8.73
- Adherium has Income of -AUD$8.72
- Legend Mining has Income of -AUD$8.72
- Pil Italica Lifestyle has Income of -₨8.72
- Major has Income of -HKD$8.71
- NexPoint Real Estate Finance Inc has Income of -$8.71